We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
-11.43%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$19.8B
AUM Growth
-$2.83B
Cap. Flow
+$212M
Cap. Flow %
1.07%
Top 10 Hldgs %
15.28%
Holding
2,395
New
108
Increased
1,282
Reduced
892
Closed
107

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$32.7M
2
CI icon
Cigna
CI
+$31.5M
3
LYB icon
LyondellBasell Industries
LYB
+$27.6M
4
VICI icon
VICI Properties
VICI
+$24.4M
5
CVS icon
CVS Health
CVS
+$21.2M

Sector Composition

Rank Sector Weight
1 Technology 17.58%
2 Financials 16.18%
3 Healthcare 14.54%
4 Consumer Discretionary 9.94%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNE
1926
DELISTED
Veoneer, Inc.
VNE
$309K ﹤0.01%
13,126
-711
-5% -$25K
CTS icon
1927
CTS Corp
CTS
$1.76B
$308K ﹤0.01%
11,878
+1,189
+11% +$33.7K
HRTX icon
1928
Heron Therapeutics
HRTX
$93.4M
$308K ﹤0.01%
11,885
-1,828
-13% -$50.3K
OFG icon
1929
OFG Bancorp
OFG
$2.21B
$308K ﹤0.01%
18,708
-109
-0.6% -$1.83K
SHOE
1930
Shoe Station Group
SHOE
$424M
$308K ﹤0.01%
18,390
+176
+1% +$3.26K
UPBD icon
1931
Upbound Group
UPBD
$1.22B
$308K ﹤0.01%
19,022
-335
-2% -$4.86K
BMTC
1932
DELISTED
Bryn Mawr Bank Corp
BMTC
$307K ﹤0.01%
8,928
+4,222
+90% +$167K
CORT icon
1933
Corcept Therapeutics
CORT
$9.98B
$306K ﹤0.01%
22,872
+8,351
+58% +$110K
GOOD
1934
Gladstone Commercial Corp
GOOD
$623M
$306K ﹤0.01%
17,077
-2,435
-12% -$45.7K
COWN
1935
DELISTED
Cowen Inc. Class A Common Stock
COWN
$306K ﹤0.01%
22,964
+8,499
+59% +$129K
RMR icon
1936
The RMR Group
RMR
$335M
$305K ﹤0.01%
5,751
-3,546
-38% -$251K
TGI
1937
DELISTED
Triumph Group
TGI
$305K ﹤0.01%
26,526
+9,360
+55% +$163K
GHDX
1938
DELISTED
Genomic Health, Inc.
GHDX
$305K ﹤0.01%
4,728
+1,352
+40% +$94.8K
EXTN
1939
DELISTED
Exterran Corporation
EXTN
$304K ﹤0.01%
17,201
+9,094
+112% +$204K
KBAL
1940
DELISTED
Kimball International
KBAL
$303K ﹤0.01%
21,327
+1,044
+5% +$16.3K
IMPV
1941
DELISTED
Imperva, Inc.
IMPV
$303K ﹤0.01%
+5,446
New +$296K
SXI icon
1942
Standex International
SXI
$3.33B
$301K ﹤0.01%
4,476
+743
+20% +$62.3K
STAY
1943
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$301K ﹤0.01%
19,421
+519
+3% +$9.14K
CATO icon
1944
Cato Corp
CATO
$65.7M
$300K ﹤0.01%
21,036
-4,979
-19% -$85.8K
FARO
1945
DELISTED
Faro Technologies
FARO
$300K ﹤0.01%
7,371
+820
+13% +$39.8K
NCMI icon
1946
National CineMedia
NCMI
$378M
$299K ﹤0.01%
4,617
+454
+11% +$35.7K
VNDA icon
1947
Vanda Pharmaceuticals
VNDA
$304M
$299K ﹤0.01%
+11,442
New +$269K
WBD icon
1948
Warner Bros
WBD
$64.3B
$297K ﹤0.01%
12,010
-2,802
-19% -$85.3K
ZWS icon
1949
Zurn Elkay Water Solutions
ZWS
$8.55B
$297K ﹤0.01%
26,849
+2,419
+10% +$31.4K
GIII icon
1950
G-III Apparel Group
GIII
$1.54B
$296K ﹤0.01%
10,630
+1,171
+12% +$43.4K

Similar funds

Aperio Group's Q4 2018 Portfolio in Review

As of Q4 2018, Aperio Group held 2,395 positions worth $19.8B, down 12% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aperio Group's Q4 2018 filing shows 108 new, 1,282 increased, 892 reduced and 107 closed positions. Its largest new stake was Linde: 206,771 shares worth $32.3M. The largest sale was Aetna Inc, an estimated $67.4M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2018 buy was Linde: 206,771 shares worth $32.3M.
  • Aperio Group added most to Cigna in Q4 2018, an estimated $31.5M increase.
  • Aperio Group's biggest Q4 2018 reduction was Apple, cutting an estimated $28.3M.
  • Aperio Group fully exited Aetna Inc in Q4 2018, selling an estimated $67.4M.
  • Aperio Group's ten largest holdings make up 15% of its $19.8B portfolio in Q4 2018.
  • Aperio Group opened 108 new positions and closed 107 in Q4 2018.
  • Aperio Group's portfolio value fell 12% quarter-over-quarter to $19.8B.

Based on Aperio Group's 13F filing for Q4 2018, filed 14 Feb 2019.